Total Payments
$5,588
2024 Payments
$858.44
Companies
33
Transactions
241
Medicare Patients
4,679
Medicare Billing
$353,410
Payment Breakdown by Category
Food & Beverage$5,558 (99.5%)
Education$30.54 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,558 | 239 | 99.5% |
| Education | $30.54 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $808.88 | 34 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $629.86 | 20 | $0 (2024) |
| UCB, Inc. | $600.47 | 21 | $0 (2024) |
| GENZYME CORPORATION | $329.97 | 15 | $0 (2024) |
| Merz North America, Inc. | $318.28 | 4 | $0 (2019) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $274.86 | 15 | $0 (2020) |
| Galderma Laboratories, L.P. | $243.69 | 9 | $0 (2022) |
| PFIZER INC. | $231.87 | 17 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $226.05 | 9 | $0 (2024) |
| MAYNE PHARMA INC. | $215.79 | 12 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $858.44 | 40 | GENZYME CORPORATION ($164.73) |
| 2023 | $407.98 | 19 | Amgen Inc. ($108.97) |
| 2022 | $379.63 | 19 | Regeneron Healthcare Solutions, Inc. ($61.29) |
| 2021 | $123.07 | 6 | AbbVie Inc. ($27.00) |
| 2020 | $454.96 | 22 | Allergan, Inc. ($117.44) |
| 2019 | $2,380 | 107 | AbbVie, Inc. ($437.52) |
| 2018 | $727.06 | 22 | UCB, Inc. ($207.17) |
| 2017 | $256.82 | 6 | Novartis Pharmaceuticals Corporation ($239.80) |
All Payment Transactions
241 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $8.96 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Immunology | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply), Odomzo | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: Immunology | ||||||
| 11/20/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $7.79 | General |
| Category: Immunology | ||||||
| 11/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Dermatology | ||||||
| 10/22/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Dermatology | ||||||
| 10/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Immunology | ||||||
| 10/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Immunology | ||||||
| 10/02/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $17.90 | General |
| 09/04/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Dermatology | ||||||
| 08/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Immunology | ||||||
| 08/01/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $26.74 | General |
| Category: Immunology | ||||||
| 08/01/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $1.78 | General |
| Category: Immunology | ||||||
| 07/26/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Dermatology | ||||||
| 07/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: IMMUNOLOGY | ||||||
| 07/24/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Immunology | ||||||
| 07/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: IMMUNOLOGY | ||||||
| 07/18/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: Dermatology | ||||||
| 07/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: IMMUNOLOGY | ||||||
| 06/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Immunology | ||||||
| 06/18/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Immunology | ||||||
| 06/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.41 | General |
| Category: IMMUNOLOGY | ||||||
| 05/21/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,408 | 2,213 | $207,598 | $91,275 |
| 2022 | 15 | 1,176 | 2,088 | $181,092 | $95,142 |
| 2021 | 18 | 1,561 | 3,058 | $273,058 | $130,852 |
| 2020 | 9 | 534 | 902 | $90,262 | $36,142 |
Total Patients
4,679
Total Services
8,261
Medicare Billing
$353,410
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 282 | 364 | $47,213 | $23,234 | 49.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 175 | 192 | $32,213 | $13,728 | 42.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 122 | 138 | $22,382 | $11,598 | 51.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 77 | 89 | $17,263 | $8,717 | 50.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 193 | 226 | $23,268 | $8,354 | 35.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 106 | 115 | $9,942 | $4,525 | 45.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 28 | 29 | $11,890 | $4,017 | 33.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 61 | 61 | $10,559 | $3,747 | 35.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 137 | 623 | $10,853 | $3,272 | 30.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 54 | 76 | $6,506 | $3,101 | 47.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $4,788 | $2,330 | 48.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 39 | 39 | $4,191 | $1,836 | 43.8% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 12 | 12 | $2,464 | $1,280 | 52.0% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 24 | 30 | $2,501 | $924.46 | 37.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 32 | 46 | $1,033 | $488.46 | 47.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 48 | 155 | $532.75 | $123.16 | 23.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 302 | 486 | $62,295 | $33,350 | 53.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 143 | 167 | $24,283 | $12,197 | 50.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 104 | 134 | $21,543 | $12,018 | 55.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 147 | 209 | $20,031 | $8,794 | 43.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 92 | 127 | $10,212 | $5,751 | 56.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 69 | 69 | $11,082 | $5,272 | 47.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 35 | 48 | $8,644 | $4,846 | 56.1% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 13 | 13 | $5,629 | $3,272 | 58.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 105 | 537 | $5,026 | $2,912 | 57.9% |
About Dr. Ryan Rich, MD
Dr. Ryan Rich, MD is a Dermatology healthcare provider based in Rogers, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2011. The National Provider Identifier (NPI) number assigned to this provider is 1578852455.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Rich, MD has received a total of $5,588 in payments from pharmaceutical and medical device companies, with $858.44 received in 2024. These payments were reported across 241 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($5,558).
As a Medicare-enrolled provider, Rich has provided services to 4,679 Medicare beneficiaries, totaling 8,261 services with total Medicare billing of $353,410. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Rogers, AR
- Active Since 03/31/2011
- Last Updated 06/09/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1578852455
Products in Payments
- COSENTYX (Biological) $546.75
- DUPIXENT (Biological) $504.36
- Cimzia (Drug) $451.14
- Humira (Biological) $334.13
- EUCRISA (Drug) $201.33
- DORYX (Drug) $199.22
- DUOBRII (Drug) $180.83
- SKYRIZI (Biological) $177.08
- Otezla (Drug) $173.57
- Bimzelx (Biological) $149.33
- Skyrizi (Biological) $140.27
- TALTZ (Drug) $123.64
- RINVOQ (Biological) $111.12
- ENSTILAR (Drug) $103.03
- REMICADE (Biological) $88.58
- COSENTYX (Drug) $83.11
- SPEVIGO (Drug) $78.95
- Sitavig (Drug) $71.62
- BRYHALI (Drug) $66.37
- BLU-U (Medical Supply) $60.38
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.